Ocumension Therapeutics - Insider Non-Derivative Transactions at EyePoint Pharmaceuticals, Inc. (EYEP) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 11, 2024, Ocumension Therapeutics's relationship to EyePoint Pharmaceuticals, Inc. (EYEP) is Director, and currently has 100,221 shares of common stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other EYEP insiders.
Data Source: SEC.
Ocumension Therapeutics - Insider Non-Derivative Transactions of EYEP common stock
Ocumension Therapeutics - Insider Non-Derivative Transactions at EYEP
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 12, 2024 | Sell -- (common stock) | 1910500 | 19.45 | 100221 |
| Dec 7, 2023 | Sell -- (common stock) | 266242 | 18.41 | 2010721 |
| Dec 6, 2023 | Sell -- (common stock) | 733758 | 19.91 | 2276963 |